CONTEXT: Report of a peer reviewed study published in the journal “Therapeutic Advances in Endocrinology and Metabolism” (TAEM) on subcutaneous testosterone pellets for long term hormone therapy in men and Continue Reading
CONTEXT: Transcript of a poster presentation made at the National Comprehensive Cancer Network (NCCN) Annual Conference 2021 on real-world outcomes of febrile neutropenia among patients with breast cancer or non-hodgkin Continue Reading
CONTEXT: Interesting and powerful use of real-world data in Scotland to inform health policy decisions. This researcher shows clear evidence that minimum unit pricing for alcohol reduced the purchasing of Continue Reading
CONTEXT: A philanthropy-fuelled database created at the University of Calgary is proving its value and attracting international attention, including for some highly encouraging new research for treating lung cancer (NSCLC) | Cananda only data Continue Reading
CONTEXT: Report of a paper published in Immunotherapy, May 26th 2021 edition describing RWE study of PD-L1 testing patterns and treatment distribution in patients with NSCLC in Israel. The results Continue Reading
CONTEXT: Commercial announcement of a joint initiative between Hoffmann-La Roche and BC Cancer along with Canadian Personalised Healthcare Innovation Network (CPHIN) to create an RWE framework in British Columbia to Continue Reading
CONTEXT: Report of a retrospective cohort study publish in JAMA Network Open describing the use of Keytruda (Pembrolizumab) alone and in combination with chemotherapy in the treatment of NSCLC | Continue Reading
CONTEXT: As promised, we will keep you up to date on the FDA guidance on RWE in pediatric oncology. It seems the guidance will be available soon, but following a Continue Reading
CONTEXT: Commercial announcement of Picnic Health and Komodo Health partnership to support RWE programs for complex illnesses like MS and haemophilia. IMPACT: Low READ TIME: 1 min Quality Level Mean Continue Reading
CONTEXT: RWE data presented at the Digestive Disease Week (DDW) 2021 evaluated the prevalence and predictors of immunomodulator use as concomitant therapy with two commonly prescribed biologics. IMPACT: Low Continue Reading
